Iovance Biotherapeutics Inc
(IOVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | N/A | 16 | N/A |
| Other current assets | 5 | 5 | 5 | 9 | 34 |
| TOTAL | $8 | $7 | $5 | $24 | $34 |
| Non-Current Assets | |||||
| PPE Net | 20 | 22 | 24 | 25 | 27 |
| Other Non-Current Assets | 0 | 0 | 0 | 16 | 16 |
| TOTAL | $20 | $22 | $24 | $41 | $43 |
| Total Assets | $28 | $29 | $29 | $66 | $77 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,292 | 1,098 | 842 | 609 | 504 |
| Accrued Expenses | 4,234 | 3,769 | 1,628 | 1,118 | 1,146 |
| Other current liabilities | N/A | N/A | 7,660 | 8,740 | 10,668 |
| TOTAL | $12,307 | $11,349 | $16,610 | $16,684 | $17,335 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $12,307 | $11,349 | $16,610 | $16,684 | $17,335 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,094 | 15,094 | 783 | 783 | 783 |
| Common Shares | 245 | 245 | 501 | 501 | 3 |
| Retained earnings | -31,731 | -30,684 | -34,150 | -33,477 | -33,149 |
| TOTAL | $-12,279 | $-11,320 | $-16,582 | $-16,618 | $-17,259 |
| Total Liabilities And Equity | $28 | $29 | $29 | $66 | $77 |